ARCHIVES

Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives.

This article is from The Cancer Letter archive.

Vol. 29 No. 36 | October 3, 2003

Download PDF Visit The Full Archive

Related Articles

Obituary: Rajka Medenica, controversial Physician

December 5, 1997

NCI Is Convinced It Has Isolated Human Cancer Virus

February 14, 1975

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

President Asks $989.3 Million fr NCI, But Mistake In Grant Allocations May Lead To Additional Money

February 4, 1983

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009